Morphine Sulphate Fresenius 10 mg/1 ml & 15 mg/1 ml Solution for injection/infusion.
PDF Leaflet Revision Date: 03 March 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Relief of intractable pain not controlled with non-narcotic analgesics.
Dosage (summary)
Adults: 5 to 20 mg every 4 hours; IV: up to 15 mg; maintenance: 0.8 to 80 mg/hour.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Safety not established; may cause dependence in fetus and respiratory depression in neonate.
Key Drug Interactions
- CNS depressants
- Sedatives
- MAO inhibitors
- P2Y12 inhibitors
Contraindications
- Hypersensitivity
- Respiratory depression
- Acute alcoholism
- Biliary colic
Common side effects
- Drowsiness
- Nausea
- Constipation
- Pruritus
Counselling Points
- Avoid driving or operating machinery
- Monitor for signs of respiratory depression
- Discuss treatment goals and discontinuation plan
Serious warnings
- Risk of abuse and dependence
- Respiratory depression
- Sedation with concomitant use of CNS depressants
Important Disclaimer
The Morphine Sulphate Fresenius 10 mg/1 ml & 15 mg/1 ml Solution for injection/infusion. professional information leaflet below is the property of Fresenius Kabi Manufacturing Sa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
